Vincent Wong

What’s the best way to implement the 2-step clinical care pathway for evaluating MASLD? Is it as effective as VCTE for all patients? Check out this paper in J Hep: authors.elsevier.com/sd/article/S01…. Congrats to @TerryYip12 and the VCTE-Prognosis Study Team! 🎉 #MASLD #ClinicalResearch

A new blood-based biomarker for #MASH has been confirmed in diverse US and Chinese populations. Amazing collaboration among @CUHKMedicine, @UCSDHealth, and Wenzhou Medical University! Read more in Cell Metabolism: sciencedirect.com/science/articl…

This is probably the first MetALD Conference ever. Thank you, @DrLoomba, for hosting this in San Diego!
metaldconference.org

Achieving SVR doesn’t mean you’re free from liver cancer. The new AI-Safe-C score can identify patients at residual cancer risk. Stay informed! Congratulations, Huapeng! #Hepatology #LiverCancer #AI
journal-of-hepatology.eu/article/S0168-…

Non-invasive tests are proving to be as good as, if not better than, liver biopsy in predicting patient prognosis for steatotic liver disease. #LiverDisease #MedicalResearch doi: 10.1001/jama.2024.1447